ConductScience.org, home

Gene · 690

BTF3P11: basic transcription factor 3 pseudogene 11

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. BTF3P11: basic transcription factor 3 pseudogene 11. Genes, record 690. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/690

On this page

Gene

Symbol
BTF3P11
HGNC
Name
basic transcription factor 3 pseudogene 11
HGNC
NCBI Gene ID
690
NCBI Gene
HGNC ID
HGNC:1126
HGNC
Ensembl
ENSG00000118903
NCBI Gene
Aliases
BRF3L1, BTF3L1, HUMBTFB, OCIF, OPG, TNFRSF11B
NCBI Gene
Type
pseudo
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants834

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleBTF3P11 papersNewest fiscal year
K23HL151876Necroinflammatory Cell Death in Sepsis42025
P30CA091842Cancer Center Support Grant42025
R01AG069901ADMINISTRATIVE SUPPLEMENT - TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's disease42025
R01DE024450Integrative Predictors of Temporomandibular Degenerative Joint Disease42025
P30CA016087Cancer Center Support Grant32025
P30CA016672Cancer Center Support Grant32025
R01CA209882Contribution of osteocytes to the musculoskeletal effects of Multiple Myeloma32025
I01RX003552"Novel therapeutic approaches to improve fracture healing while reducing pain behavior"22025
IK6RX004809RR&D Research Career Scientist Award Application22025
P20GM125503Center for Musculoskeletal Disease Research (CMDR)22025

1 to 10 of 834Source NIH's project files

See all 834 nih grants

Papers2,843

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Bibliometric mapping of the 100 most-cited publications on optic nerve and optic pathway glioma: A cross-sectional bibliometric analysis.Medicine (Baltimore)202642826282PubTator, text miningPubMed
Decoding melatonin's role in musculoskeletal health: mechanistic foundations and clinical applications.Indian J Orthop202642824268PubTator, text miningPubMed
Xianling Gubao Capsule for Osteoporosis: A Review of Active Components and Underlying Mechanisms.Curr Protein Pept Sci202642816999PubTator, text miningPubMed
Mechanobiology of Osteoarthritis: Interactions Between Mechanical Stress, Inflammation, and Joint Remodeling.Cell Biol Int202642808736PubTator, text miningPubMed
Trifold anisotropy and strain-driven switching in octagon-pentagon graphene nanoribbons.Phys Chem Chem Phys202642808296PubTator, text miningPubMed
Validation of Osteoporosis associated SNPs candidates from Decisive Gene Strategy using Taiwan Biobank.Int J Med Sci202642807304PubTator, text miningPubMed
The function of miR-4666a-3p in the diagnosis of osteoporotic fractures and the promotion of fracture healing.Ann Agric Environ Med202642802970PubTator, text miningPubMed
Key Inflammatory Pathways, Biomarkers, and Targeted Management Strategies in Primary Total Joint Arthroplasty: A Narrative Review.Medicina (Kaunas)202642796320PubTator, text miningPubMed
The Relationship Between Orthodontic Malocclusion Severity and Periodontal Clinical and Biochemical Parameters in Adolescents: A Cross-Sectional Study.Diagnostics (Basel)202642793714PubTator, text miningPubMed
The Circadian-Melatonin Axis in Bone Remodeling: Receptor-Dependent Signaling, Receptor-Independent Actions, and Translational Constraints.Biomolecules202642793064PubTator, text miningPubMed

1 to 10 of 2,843

See all 2,843 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/690

GET https://conductscience.org/api/genes/v1/690/grants?page=2